TARGETING GANGLIOSIDE GD2 TO OVERCOME CHEMOTHERAPY RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER

$1,788,135FY2025Defense Health AgencyDOD

Virginia Commonwealth University, Richmond VA

Investigators